Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43360

CCSER1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CRISPR/Cas9-edited polyclonal knockout HEK293T cells with disruption of the CCSER1 gene, encoding a coiled-coil serine-rich protein implicated in mitotic spindle assembly and chromosome segregation. This loss-of-function model, in a high-transfection-efficiency embryonic kidney epithelial host, enables investigation of CCSER1's role in maintaining genomic stability through interactions with tubulin and the PLK1/Aurora kinase/CDK1 mitotic regulatory network. Applications include validation via western blotting and immunofluorescence, cell cycle analysis by flow cytometry, and functional tumor biology assays such as migration and apoptosis studies, supporting research into aneuploidy and tumor suppression.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    CCSER1

    Gene Identifier

    NCBI Gene ID 401145

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCSER1 Polyclonal Knockout HEK293T Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the human CCSER1 gene in HEK293T embryonic kidney epithelial cells. This heterogeneous pool provides a robust loss-of-function model for investigating CCSER1’s roles in mitosis, chromosome segregation, and tumor suppression. The polyclonal format captures diverse editing events across the population, enabling functional studies without clonal selection while retaining the high transfection efficiency and rapid growth characteristic of the HEK293T background.

HEK293T cells, a derivative of HEK293, stably express the SV40 large T antigen, which facilitates episomal replication of SV40 origin-containing plasmids, thereby greatly enhancing protein expression and viral packaging capabilities. These adherent, human-derived cells are widely employed for transient and stable protein production, lentiviral and retroviral packaging, and mechanistic cell biology studies. Their well-characterized signaling networks and ease of genetic manipulation make them an ideal host for probing gene function in pathways governing cell cycle control and genomic stability.

CCSER1 encodes a coiled-coil serine-rich protein that localizes to the mitotic spindle and is implicated in the regulation of spindle assembly and chromosome segregation fidelity. Mechanistically, CCSER1 interacts with ??/??-tubulin and microtubule-associated proteins, contributing to microtubule dynamics and spindle pole organization. It operates within a mitotic network encompassing PLK1, Aurora kinases, and the cyclin B/CDK1 complex, which are critical for mitotic entry and checkpoint control. Upstream, cell cycle-dependent transcription factors and mitogenic signaling cascades likely regulate CCSER1 expression, while downstream, its loss may dysregulate cyclin-dependent kinases and the chromosome segregation machinery, potentially leading to cohesion defects and aneuploidy. Thus, CCSER1 links spindle mechanics to mitotic checkpoint surveillance.

In the HEK293T cellular context, CRISPR/Cas9-mediated disruption of CCSER1 creates a powerful system for dissecting mitotic spindle regulation and the consequences of chromosome mis-segregation. Researchers can readily assess spindle morphology, mitotic progression, and ploidy changes in a biochemically tractable model. The polyclonal knockout population is particularly suited for pooled functional genomics screens and for capturing heterogeneous cellular responses to checkpoint disruption, mirroring the genetic variability observed in tumor cell populations.

These CCSER1 knockout cells support a broad spectrum of applications in tumor biology, aneuploidy research, and CRISPR validation. Representative experimental workflows include western blotting and RT-qPCR to confirm CCSER1 depletion, immunofluorescence microscopy to visualize spindle defects, flow cytometric analysis of cell cycle profiles and DNA content, and functional assays such as migration, invasion, and apoptosis to evaluate oncogenic phenotypes. Transcriptomic profiling by RNA-seq can further elucidate pathway alterations. This model thus provides a versatile platform for preclinical cancer research and drug discovery targeting mitotic regulators. For detailed product specifications or technical assistance, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)